A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial
Eric M. Thompson, David M. Ashley, Katayoun Ayasoufi, Pamela K. Norberg, Gerald Archer, Evan Buckley, James E. Herndon, Ashley A. Walter, Bridget Archambault, Charlene Flahiff, Denise Jaggers, Laura Gorski, Luis A. Sánchez, Kendra L. Congdon, Kelly Hotchkiss, Sarah Cook, Eliese Moelker, Gordana Vlahovic, Elizabeth A. Reap, Kristin Schroeder, Dina Randazzo, Annick Desjardins, Margaret Johnson, Katherine B. Peters, Mustafa Khasraw, Henry S. Friedman, Duane A. Mitchell, John H. Sampson, Daniel Landi
Topics & Concepts
MedulloblastomaGliomaMedicinePeptide vaccineAntigenPeptideVirologyOncologyCancer researchImmunologyBiologyEpitopeBiochemistryImmunotherapy and Immune ResponsesCytomegalovirus and herpesvirus researchCAR-T cell therapy research